Toronto, Ontario (Newsfile Corp. - February 14, 2022) - High Fusion Inc. (CSE: FUZN) ("High Fusion" or the "Company") is pleased to announce that it will complete a conversion of its second secured debentures
Toronto, Ontario (Newsfile Corp. - February 3, 2022) - High Fusion Inc. (CSE: FUZN) ("High Fusion" or the "Company") is pleased to announce that its subsidiary, Neural Therapeutics Inc. ("Neural Therapeutics")
Toronto, Ontario (Newsfile Corp. - January 20, 2022) - High Fusion Inc. (CSE: FUZN) ("High Fusion" or the "Company") is pleased to announce its financial results for the first quarter ended October 31
Toronto, Ontario (Newsfile Corp. - January 14, 2022) - High Fusion Inc. (CSE: FUZN) ("High Fusion" or the "Company") provides this bi-weekly default status report in accordance with National Policy 12-203
Toronto, Ontario (Newsfile Corp. - January 4, 2022) - High Fusion Inc. (CSE: FUZN) ("High Fusion" or the "Company") is pleased to announce the filing of a business acquisition report including financial